Asia Pacific Neurotoxins Market Forecast to 2028 -Regional Analysis - by Product Type (Botox, Dysport, Xenomin, and Others), Application (Therapeutic and Aesthetic), and End User (Hospitals, Specialty Clinics, Dermatology Clinics, and Others)

Asia Pacific Neurotoxins Market Forecast to 2028-Regional Analysis- by Product Type (Botox, Dysport, Xenomin, and Others), Application (Therapeutic and Aesthetic), and End User (Hospitals, Specialty Clinics, Dermatology Clinics, and Others)


The Asia Pacific neurotoxins market is expected to grow from US$ 925.29 million in 2023 to US$ 1,858.41 million by 2028. It is estimated to register a CAGR of 15.0% from 2023 to 2028.

Surge in Cosmetic Procedures to Improve Appearance Fuels Asia Pacific Neurotoxins Market

Structural changes affecting the skin, muscles, ligaments, fat, and bone get noticeable on an individual’s face due to decrease in cellular functions with aging. The inevitable physiological process of aging is generally not conceived positively by many, which, in turn, urges them to indulge in cosmetic rejuvenation procedures to remain youthful visually. Botulinum toxin (BOTA)—which is naturally produced by Clostridium botulinum—is the most popular neurotoxin used in cosmetic procedures. Therefore, the rising popularity of cosmetic procedures involving neurotoxins to reduce facial wrinkles while ensuring safety, effectivity, and efficiency is catalyzing the market for neurotoxins.

Asia Pacific Neurotoxins Market Overview

The Asia Pacific neurotoxin market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. The increasing product developments and launches, growing numbers of aesthetic procedures, rising distribution by companies for neurotoxin products, and increasing demand for non-surgical aesthetic procedures among the young population are driving the growth of the market in the region. The Australian neurotoxin market is expected to have growth opportunities due to growing developments in the pharmaceutical industry. The country has several facilities, such as manufacturing, research and development, and a good distribution network. Also, the country is among the region's top countries performing aesthetic procedures. However, the market for neurotoxins is highly regulated in the country. The botulinum toxin products are classified as S4 pharmaceuticals; hence they are only administered by a doctor or a nurse. Also, the regulatory bodies strictly regulate the products in the country, and the brands approved by Therapeutic Goods Administration (TGA) in Australia are Botox, Dysport, and Xeomin.

Asia Pacific Neurotoxins Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Neurotoxins Market Segmentation

The Asia Pacific neurotoxins market is segmented into product type, application, end user, and country.

Based on product type, the Asia Pacific neurotoxins market is subsegmented into botox, dysport, xenomin, and others. The botox segment registered the largest market share in 2023.

Based on application, the Asia Pacific neurotoxins market is segmented into therapeutic and aesthetic. The therapeutic segment held a larger market share in 2023.

Based on end user, the market is segmented into hospitals, specialty clinics, dermatology clinics, and others. The hospitals segment held the largest market share in 2023.

Based on country, the market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. Japan dominated the market share in 2023.

AbbVie Inc, Gufic, Hugel Inc, Ipsen SA, Lanzhou Institute of Biological Products Co Ltd, Medytox Inc, and Merz Pharma GmbH & Co KGaA are among the leading companies operating in the Asia Pacific neurotoxins market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific neurotoxins market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific neurotoxins market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the neurotoxins market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution


1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Neurotoxin Market - by Type
1.3.2 Asia Pacific Neurotoxin Market - by Application
1.3.3 Asia Pacific Neurotoxin Market - by End User
1.3.4 Asia Pacific Neurotoxin Market - by Country
2. Asia Pacific Neurotoxin Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Neurotoxin Market - Market Landscape
4.1 Overview
4.2 Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Neurotoxin Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Surge in Cosmetic Procedures to Improve Appearance
5.1.2 Emergence of Innovative Facial Aesthetic Products
5.2 Market Restraints
5.2.1 Improper/Inappropriate Injection Technique
5.3 Future Trends
5.3.1 BOTA for Assisted Reproductive Technology (ART)
5.4 Impact Analysis
6. Asia Pacific Neurotoxin Market
6.1 Asia Pacific Neurotoxin Market Revenue Forecast and Analysis
7. Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 - By Type
7.1 Overview
7.2 Asia Pacific Neurotoxin Market Revenue Share, by Type (2022 and 2028)
7.3 Botox
7.3.1 Overview
7.3.2 Botox: Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Dysport
7.4.1 Overview
7.4.2 Dysport: Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Xeomin
7.5.1 Overview
7.5.2 Xeomin: Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 - By Application
8.1 Overview
8.2 Asia Pacific Neurotoxin Market Revenue Share, by Application (2022 and 2028)
8.3 Therapeutic
8.3.1 Overview
8.3.2 Therapeutic: Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Aesthetic
8.4.1 Overview
8.4.2 Aesthetic: Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 - By End User
9.1 Overview
9.2 Asia Pacific Neurotoxin Market Revenue Share, by End User (2022and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Medical Spas and Beauty Centers
9.4.1 Overview
9.4.2 Medical Spas and Beauty Centers: Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Dermatology Clinics
9.5.1 Overview
9.5.2 Dermatology Clinics: Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Neurotoxin Market -Revenue and Forecast to 2028- Country Analysis
10.1 Overview
10.1.1 Asia Pacific: Neurotoxin Market, by Country, 2022 & 2028 (%)
10.1.1.1 Australia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Australia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Australia: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.1.1.4 Australia: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.1.1.5 Australia: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.1.2 China: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 China: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 China: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.1.2.4 China: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.1.2.5 China: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.1.3 India: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 India: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.1.3.4 India: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.1.3.5 India: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.1.4 Japan: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Japan: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Japan: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.1.4.4 Japan: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.1.4.5 Japan: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.1.5 South Korea: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 South Korea: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 South Korea: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.1.5.4 South Korea: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.1.5.5 South Korea: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
11. Asia Pacific Neurotoxins Market-Industry Landscape
11.1 Overview
11.2 Organic Growth Strategies
11.2.1 Overview
11.3 Inorganic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Merz Pharma GmbH & Co KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 AbbVie Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Ipsen SA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Medytox Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Hugel Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Lanzhou Institute of Biological Products Co Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Gufic
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Neurotoxins Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. Australia Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 3. Australia Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 4. Australia Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 5. China: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 6. China: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 7. China: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 8. India: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 9. India: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 10. India: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 11. Japan: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 12. Japan: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 13. Japan: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 14. South Korea: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 15. South Korea: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 16. South Korea: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Asia Pacific: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Asia Pacific: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of Asia Pacific: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 20. Recent Organic Growth Strategies in Neurotoxins Market
Table 21. Recent Inorganic Growth Strategies in the Neurotoxins Market
Table 22. Glossary of Terms
LIST OF FIGURES
Figure 1. Asia Pacific Neurotoxin Market Segmentation
Figure 2. Asia Pacific Neurotoxin Market by Country
Figure 3. Asia Pacific Neurotoxin Market Overview
Figure 4. Asia Pacific Neurotoxin Market, By Type
Figure 5. Asia Pacific Neurotoxin Market, By Country
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Asia Pacific Neurotoxin Market: Impact Analysis of Drivers and Restraints
Figure 8. Asia Pacific Neurotoxin Market - Revenue Forecast and Analysis - 2021-2028
Figure 9. Asia Pacific Neurotoxin Market Revenue Share, by Type (2022 and 2028)
Figure 10. Botox: Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 11. Dysport: Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Xeomin: Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Asia Pacific Neurotoxin Market Revenue Share, by Application (2022 and 2028)
Figure 15. Therapeutic: Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Aesthetic: Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Asia Pacific Neurotoxin Market Revenue Share, by End User (2022 and 2028)
Figure 18. Hospitals: Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Medical Spas and Beauty Centers: Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Dermatology Clinics: Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Asia Pacific: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
Figure 23. Asia Pacific: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 24. Australia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. China: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. India: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Japan: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. South Korea: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Rest of Asia Pacific: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings